This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Serge Rozenberg, MD; Jean Vandromme, MD; H. Ham, MD
Free Universities of Brussels Brussels, Belgium

JAMA. 1997;278(6):475.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.

—Dr Col and colleagues¹ have proposed a partitioning diagram, based on the presence of risk factors for cardiovascular disease, breast cancer, and osteoporosis, to identify patients who would benefit from hormone replacement therapy (HRT). We recently conducted a survey evaluating the attitude of Belgian gynecologists concerning HRT initiation. We used hypothetical cases that were created with different risk levels of cardiovascular disease, osteoporosis, and breast cancer. A total of 4108 cases were analyzed.² No cases with left ventricular hypertrophy, a systolic pressure of greater than 174 mm Hg, or more than 1 relative with breast cancer were included, but the other risk factors used by Col et al were present. The hip fracture risk was based on the T score obtained with the vertebral bone mineral measurement, using the definitions for low bone mass (T score, <-1) and osteoporosis (T score, <-2) as suggested by . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?